O
HZNP
OrbiMed’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-266,400
| Closed | -$30.8M | – | 136 |
|
|
2023
Q3 | $30.8M | Sell |
266,400
-50,000
| -16% | -$5.78M | 0.65% | 56 |
|
|
2023
Q2 | $32.5M | Buy |
316,400
+116,400
| +58% | +$12M | 0.59% | 55 |
|
|
2023
Q1 | $21.8M | Buy |
200,000
+29,000
| +17% | +$3.17M | 0.43% | 63 |
|
|
2022
Q4 | $19.5M | Buy |
+171,000
| New | +$19.5M | 0.37% | 65 |
|
|
2022
Q3 | – | Sell |
-2,108,555
| Closed | -$168K | – | 152 |
|
|
2022
Q2 | $168K | Sell |
2,108,555
-88,000
| -4% | -$7.02K | 3.05% | 4 |
|
|
2022
Q1 | $231M | Sell |
2,196,555
-303,500
| -12% | -$31.9M | 3.75% | 2 |
|
|
2021
Q4 | $269M | Sell |
2,500,055
-110,300
| -4% | -$11.9M | 3.46% | 3 |
|
|
2021
Q3 | $286M | Sell |
2,610,355
-311,800
| -11% | -$34.2M | 3.14% | 3 |
|
|
2021
Q2 | $274M | Sell |
2,922,155
-222,200
| -7% | -$20.8M | 2.77% | 7 |
|
|
2021
Q1 | $289M | Buy |
3,144,355
+135,600
| +5% | +$12.5M | 2.71% | 6 |
|
|
2020
Q4 | $220M | Hold |
3,008,755
| – | – | 1.93% | 12 |
|
|
2020
Q3 | $234M | Buy |
3,008,755
+140,845
| +5% | +$10.9M | 2.94% | 6 |
|
|
2020
Q2 | $159M | Buy |
2,867,910
+526,210
| +22% | +$29.2M | 2.24% | 15 |
|
|
2020
Q1 | $69.4M | Buy |
2,341,700
+759,400
| +48% | +$22.5M | 1.17% | 31 |
|
|
2019
Q4 | $57.3M | Buy |
+1,582,300
| New | +$57.3M | 0.82% | 40 |
|
|
2015
Q4 | – | Sell |
-204,000
| Closed | -$4.04M | – | 135 |
|
|
2015
Q3 | $4.04M | Sell |
204,000
-747,000
| -79% | -$14.8M | 0.04% | 110 |
|
|
2015
Q2 | $33M | Sell |
951,000
-124,000
| -12% | -$4.31M | 0.28% | 65 |
|
|
2015
Q1 | $27.9M | Hold |
1,075,000
| – | – | 0.24% | 64 |
|
|
2014
Q4 | $13.9M | Buy |
1,075,000
+179,000
| +20% | +$2.31M | 0.13% | 85 |
|
|
2014
Q3 | $11M | Buy |
896,000
+350,000
| +64% | +$4.3M | 0.11% | 87 |
|
|
2014
Q2 | $8.64M | Buy |
546,000
+350,000
| +179% | +$5.54M | 0.1% | 87 |
|
|
2014
Q1 | $2.96M | Buy |
+196,000
| New | +$2.96M | 0.04% | 112 |
|